{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:40:29Z","timestamp":1782463229305,"version":"3.54.5"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:p>This article explores the circumstances under which providers and patients should be able to attempt drugs or combinations for indications for which we still lack formal clinical trials.<\/jats:p>","DOI":"10.1634\/theoncologist.2016-0086","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T07:22:14Z","timestamp":1468308134000},"page":"1031-1032","source":"Crossref","is-referenced-by-count":6,"title":["Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies"],"prefix":"10.1093","volume":"21","author":[{"given":"Sham","family":"Mailankody","sequence":"first","affiliation":[{"name":"Myeloma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Prasad","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA"},{"name":"Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland, Oregon, USA"},{"name":"Center for Health Care Ethics, Oregon Health & Science University, Portland, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"key":"2021122309525621900_B1","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1200\/JCO.2014.56.0466","article-title":"Learning while caring: Medicine\u2019s epistemology","volume":"32","author":"Hellman","year":"2014","journal-title":"J Clin Oncol"},{"key":"2021122309525621900_B2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jamaoncol.2015.0373","article-title":"Five years of cancer drug approvals: Innovation, efficacy, and costs","volume":"1","author":"Mailankody","year":"2015","journal-title":"JAMA Oncol"},{"key":"2021122309525621900_B3","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMc1302338","article-title":"Hepatotoxicity with combination of vemurafenib and ipilimumab","volume":"368","author":"Ribas","year":"2013","journal-title":"N Engl J Med"},{"key":"2021122309525621900_B4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.2010.31.6414","article-title":"Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines","volume":"29","author":"Poonacha","year":"2011","journal-title":"J Clin Oncol"},{"key":"2021122309525621900_B5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1200\/JCO.2013.52.9123","article-title":"Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia","volume":"32","author":"Dusetzina","year":"2014","journal-title":"J Clin Oncol"},{"key":"2021122309525621900_B6","volume-title":"This drug is defying a rare form of leukemia\u2014and it keeps getting pricier","author":"Johnson"},{"key":"2021122309525621900_B7","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.2015.62.9105","article-title":"Cost-effectiveness of pertuzumab in human epidermal growth factor receptor 2\u2013positive metastatic breast cancer","volume":"34","author":"Durkee","year":"2016","journal-title":"J Clin Oncol"},{"key":"2021122309525621900_B8","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1200\/JCO.2015.61.9569","article-title":"Cost-effectiveness analysis of regorafenib for metastatic colorectal cancer","volume":"33","author":"Goldstein","year":"2015","journal-title":"J Clin Oncol"},{"key":"2021122309525621900_B9","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1200\/JCO.2014.58.1587","article-title":"Debating the oncologist\u2019s role in defining the value of cancer care: We have a duty to society","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2016-0086","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2016-0086","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/21\/9\/1031\/41875158\/oncolo_21_9_1031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/21\/9\/1031\/41875158\/oncolo_21_9_1031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T10:14:07Z","timestamp":1640254447000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/21\/9\/1031\/6401471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":9,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,7,8]]},"published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2016-0086","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,9,1]]},"published":{"date-parts":[[2016,7,8]]}}}